Crohn's disease is a complex inherited disorder of unknown pathogenesis with environmental, genetic and microbial factors involved in the development of the disease. A remarkable feature of this disease in childhood is the effective response to exclusive enteral nutrition (EEN) therapy and the need for complete exclusion of normal diet required for success (principle of exclusivity). EEN or dietary interventions might act through removal of dietary components, which affect microbial composition, decrease a proinflammatory response and promote restitution of the epithelial barrier, likewise allowing termination of this vicious disease-forming cycle before a critical threshold is reached. Multiple traditional and nontraditional dietary components may affect the microbiome, mucous layer, intestinal permeability, or adherence and translocation of pathobionts. We review the epidemiological data, as well as data from animal models and cell lines, and propose a model for pathogenesis we have termed the ‘bacterial penetration cycle', whereby dietary components such as animal fat, high sugar intake and gliadin, and consumption of emulsifiers, maltodextrin as well as low-fiber diets may be able to cause a localized acquired bacterial clearance defect, leading to bacterial adhesion and penetration, and subsequently inflammation in the gut.

Keywords:
Bacterial penetration cycle, Crohn’s disease, Diet, Environment, Fat, Emulsifiers
1.
Barrett JC, Hansoul S, Nicolae DL, et al: Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008;40:955-962.
2.
Peeters H, Bogaert S, Laukens D, et al: CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease. Int J Immunogenet 2007;34:181-191.
3.
Thompson NP, Driscoll R, Pounder RE, et al: Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ 1996;312:95-96.
4.
Cho JH, Weaver CT: The genetics of inflammatory bowel disease. Gastroenterology 2007;133:1327-1339.
5.
Martin HM, Campbell BJ, Hart CA, et al: Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004;127:80-93.
6.
Ryan P, Kelly RG, Lee G, et al: Bacterial DNA within granulomas of patients with Crohn's disease - detection by laser capture microdissection and PCR. Am J Gastroenterol 2004;99:1539-1543.
7.
Sartor B: Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134:577-594.
8.
Qiurong L, Wan C, Tan C, et al: Molecular-phylogenetic characterization of the microbiota in ulcerated and non-ulcerated regions in the patients with Crohn's disease. PLoS One 2012;7:e34939.
9.
Willing B, Dicksved J, Halfvarson J, et al: A pyrosequencing study in twins shows that the gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010;139:1844-1854.
10.
Manichanh C, Borruel N, Casellas F, et al: The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 2012;9:599-608.
11.
Bringer MA, Billard E, Glasser AL, et al: Replication of Crohn's disease-associated AIEC within macrophages is dependent on TNF-α secretion. Lab Invest 2012;92:411-419.
12.
Lapaquette P, Glasser AL, Huett A, et al: Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol 2010;12:99-113.
13.
Hviid A, Svanström H, Frisch M: Antibiotic use and inflammatory bowel diseases in childhood. Gut 2011;60:49-54.
14.
Ekbom A: Appendicectomy and childhood hygiene: different sides of the same coin? Gut 1998;43:451.
15.
Bernstein CN, Rawsthorne P, Cheang M, et al: A population-based case control study of potential risk factors for IBD. Am J Gastroenterol 2006;101:993-1002.
16.
Muegge BD, Kuczynski J, Knights D, et al: Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 2011;332:970-974.
17.
De Filippo C, Cavalieri D, Di Paola M, et al: Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 2010;107:14691-14696.
18.
Kajiura T, Takeda T, Sakata S, et al: Change of intestinal microbiota with elemental diet and its impact on therapeutic effects in a murine model of chronic colitis. Dig Dis Sci 2009;54:1892-1900.
19.
Andersen V, Olsen A, Carbonnel F, et al: Diet and risk of inflammatory bowel disease. Dig Liver Dis 2012;44:185-194.
20.
Jantchou P, Morois S, Clavel-Chapelon F, et al: Animal protein intake and risk of inflammatory bowel disease: the E3N prospective study. Am J Gastroenterol 2010;105:2195-2201.
21.
Lomer MC, Hutchinson C, Volkert S, et al: Dietary sources of inorganic microparticles and their intake in healthy subjects and patients with Crohn's disease. Br J Nutr 2004;92:947-955.
22.
Geerling BJ, Badart-Smook A, Stockbrugger RW, et al: Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur J Clin Nutr 2000;54:514-521.
23.
Tragnone A, Valpiani D, Miglio F, et al: Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995;7:47-51.
24.
Persson PG, Ahlbom A, Hellers G: Diet and inflammatory bowel disease: a case-control study. Epidemiology 1992;3:47-52.
25.
Chapman-Kiddell C, Davies P, Gillen L, et al: Role of diet in the development of inflammatory bowel disease. Inflamm Bowel Dis 2010;16:137-151.
26.
Jakobsen C, Paerregaard A, Munkholm P, et al: Environmental factors and risk of developing paediatric inflammatory bowel disease - a population based study 2007-2009. J Crohns Colitis 2013;7:79-88.
27.
Jason H, Bincy A, Hashem E: Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol 2011;106:563-573.
28.
D'Souza S, Levy E, Mack D, et al: Dietary patterns and risk for Crohn's disease in children. Inflamm Bowel Dis 2008;14:367-373.
29.
Kasper H, Sommer H: Dietary fiber and nutrient intake in Crohn's disease. Am J Clin Nutr 1979;32:1898-1901.
30.
Thornton JR, Emmett PM, Heaton KW: Diet and Crohn's disease: characteristics of the pre-illness diet. Br Med J 1979;2:762-764.
31.
Tjellström B, Högberg L, Stenhammar L, et al: Effect of exclusive enteral nutrition on gut microflora function in children with Crohn's disease. Scand J Gastroenterol 2012;47:1454-1459.
32.
Amre DK, D'Souza S, Morgan K, et al: Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol 2007;102:2016-2025.
33.
Sakamoto N, Kono S, Wakai K, et al: Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis 2005;11:154-163.
34.
Reif S, Klein I, Lubin F, et al: Pre-illness dietary factors in inflammatory bowel disease. Gut 1997;40:754-760.
35.
Martinez M, Denizot J, Dreux N, et al: Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation. Gut 2014;63:116-124.
36.
Suzuki T, Hara H: Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Nutr Metab (Lond) 2010;7:19.
37.
Devkota S, Wang Y, Musch M, et al: Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in IL10-/- mice. Nature 2012;487:104-108.
38.
Lammers K, Lu R, Brownley J, et al: Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 2008;135:194-204.
39.
Swidsinski A, Ung V, Sydora B, et al: Bacterial overgrowth and inflammation of small intestine after carboxymethylcellulose ingestion in genetically susceptible mice. Inflamm Bowel Dis 2009;15:359-364.
40.
Roberts C, Keita A, Duncan S, et al: Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifier. Gut 2010;59:1331-1339.
41.
Choi H, Kim J, Park S, et al: Pro-inflammatory NF-κB and early growth response gene 1 regulate epithelial barrier disruption by food additive carrageenan in human intestinal epithelial cell. Toxicol Lett 2012;211:289-295.
42.
Nickerson KP, McDonald C: Crohn's disease-associated adherent-invasive Escherichia coli adhesion is enhanced by exposure to the ubiquitous dietary polysaccharide maltodextrin. PLoS One 2012;7:e52132.
43.
Grover Z, Muir R, Lewindon P: Exclusive enteral nutrition induces early clinical, mucosal and transmural remission in paediatric Crohn's disease. J Gastroenterol 2013, DOI: 10.1007/s00535-013-0815-0.
44.
Buchanan E, Gaunt W, Cardigan T, et al: The use of exclusive enteral nutrition for induction of remission in children with Crohn's disease demonstrates that disease phenotype does not influence clinical remission. Aliment Pharmacol Ther 2009;30:501-550.
45.
Yamamoto T, Nakahigashi M, Umegae S, et al: Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn's disease: a prospective, non-randomized, parallel, controlled study. Aliment Pharmacol Ther 2006;25:67-72.
46.
Rubio A, Pigneur B, Garnier-Lengline H, et al: The efficacy of exclusive nutritional therapy in paediatric Crohn's disease, comparing fractionated oral vs. continuous enteral feeding. Aliment Pharmacol Ther 2011;33:1332-1339.
47.
Johnson T, Macdonald S, Hill S, et al: Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial. Gut 2006;55:356-361.
48.
Levine A, Wine E: Effects of enteral nutrition on Crohn's disease: clues to the impact of diet on disease pathogenesis. Inflamm Bowel Dis 2013;19:1322-1329.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.